Search research articles
Contact Us
Filters
Showing results (471-480 of 512) with videos related to
Page
of 52
Sort By:
Blood Advances
|
October 9, 2021
Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphoma
Chiara Pighi, Taek-Chin Cheong, Mara Compagno, et al.
Cancer Discovery
|
February 2, 2019
Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition
Daisuke Ennishi, Katsuyoshi Takata, Wendy Béguelin, et al.
Blood
|
June 2, 2011
Comprehensive analysis of mammalian miRNA* species and their role in myeloid cells
Florian Kuchenbauer, Sarah M Mah, Michael Heuser, et al.
Cell
|
July 4, 2020
TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory Fate
Leandro Venturutti, Matt Teater, Andrew Zhai, et al.
Blood
|
October 29, 2020
The impact of MYC and BCL2 structural variants in tumors of DLBCL morphology and mechanisms of false-negative MYC IHC
Brett Collinge, Susana Ben-Neriah, Lauren Chong, et al.
Nature
|
October 9, 2009
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
Sohrab P Shah, Ryan D Morin, Jaswinder Khattra, et al.
Nature Methods
|
September 14, 2010
Alternative expression analysis by RNA sequencing
Malachi Griffith, Obi L Griffith, Jill Mwenifumbo, et al.
Blood
|
March 12, 2020
Coding and noncoding drivers of mantle cell lymphoma identified through exome and genome sequencing
Prasath Pararajalingam, Krysta M Coyle, Sarah E Arthur, et al.
Blood Advances
|
June 27, 2020
Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphoma
Christopher K Rushton, Sarah E Arthur, Miguel Alcaide, et al.
The Pharmacogenomics Journal
|
January 18, 2012
Novel mRNA isoforms and mutations of uridine monophosphate synthetase and 5-fluorouracil resistance in colorectal cancer
M Griffith, J C Mwenifumbo, P Y Cheung, et al.
Page
of 52
Search research articles
Search
Showing results (471-480 of 512) with videos related to
Sort By:
Page
of 52
Blood Advances
|
October 9, 2021
Frequent mutations of FBXO11 highlight BCL6 as a therapeutic target in Burkitt lymphoma
Chiara Pighi, Taek-Chin Cheong, Mara Compagno, et al.
Cancer Discovery
|
February 2, 2019
Molecular and Genetic Characterization of MHC Deficiency Identifies EZH2 as Therapeutic Target for Enhancing Immune Recognition
Daisuke Ennishi, Katsuyoshi Takata, Wendy Béguelin, et al.
Blood
|
June 2, 2011
Comprehensive analysis of mammalian miRNA* species and their role in myeloid cells
Florian Kuchenbauer, Sarah M Mah, Michael Heuser, et al.
Cell
|
July 4, 2020
TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory Fate
Leandro Venturutti, Matt Teater, Andrew Zhai, et al.
Blood
|
October 29, 2020
The impact of MYC and BCL2 structural variants in tumors of DLBCL morphology and mechanisms of false-negative MYC IHC
Brett Collinge, Susana Ben-Neriah, Lauren Chong, et al.
Nature
|
October 9, 2009
Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
Sohrab P Shah, Ryan D Morin, Jaswinder Khattra, et al.
Nature Methods
|
September 14, 2010
Alternative expression analysis by RNA sequencing
Malachi Griffith, Obi L Griffith, Jill Mwenifumbo, et al.
Blood
|
March 12, 2020
Coding and noncoding drivers of mantle cell lymphoma identified through exome and genome sequencing
Prasath Pararajalingam, Krysta M Coyle, Sarah E Arthur, et al.
Blood Advances
|
June 27, 2020
Genetic and evolutionary patterns of treatment resistance in relapsed B-cell lymphoma
Christopher K Rushton, Sarah E Arthur, Miguel Alcaide, et al.
The Pharmacogenomics Journal
|
January 18, 2012
Novel mRNA isoforms and mutations of uridine monophosphate synthetase and 5-fluorouracil resistance in colorectal cancer
M Griffith, J C Mwenifumbo, P Y Cheung, et al.
Page
of 52